CCCC vs TM · rev $35.6M vs P/E 9.7, rev $234.60B
C4 Therapeutics Inc (CCCC) versus Toyota Motor Corporation ADR (TM) — a side-by-side from cached financials, not a winner call.
C4 Therapeutics Inc (CCCC) is a biotechnology company listed on US.
Toyota Motor Corporation ADR (TM) is a auto manufacturers company listed on NYSE.
Latest reported CCCC revenue for 2024-12-31 was $35.6M. Net income was -$105.3M. Revenue was up 71.4% from 2023-12-31 to 2024-12-31. CCCC currently screens at market cap $425.7M.
Latest reported TM revenue for 2013-03-31 was $234.60B. Net income was $10.23B. Revenue was up 3.8% from 2012-03-31 to 2013-03-31. TM currently screens at market cap $211.00B and trailing P/E 9.7.
CCCC currently screens at market cap $425.7M. TM currently screens at market cap $211.00B and trailing P/E 9.7.
Not investment advice. Open the CCCC and TM stock pages for the full models.
Not investment advice.